← Leaderboards
Elliot Tapper
University Of Michigan At Ann Arbor
$2,159,285
Attributed
$3,542,845
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $836K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,542,845 · 2
By mechanism
U01$2,767,121 · 1
K23$775,724 · 1
Top collaborators
- Neehar Dilip Parikh5 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Subramaniam Pennathur$11,719,201
- Lona Mody$10,883,116
- Neehar Dilip Parikh$2,316,206
- Melissa Elafros$708,801
- Stephen K Fisher$2,154,324
Others in their field
Other Emerging Leaders on “Cohort”
- Leonard Freedman · Leidos Biomedical Research, Inc.$70,225,348
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
- Julie Ake · National Institute Of Allergy And Infectious Diseases$52,642,120
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Scott Hensley · University Of Pennsylvania$47,346,110
- Susan M Landau · University Of California Berkeley$47,252,026
Research focus
CohortProspectiveResponseRisk StratificationPositioning AttributePreventHepatic EncephalopathyPathway InteractionsCessation Of LifeMortalityPatient Outcomes AssessmentsPortal HypertensionClinical TrialsPredictive ModelingAdverse EventComplicationDisabilityFallsBloodAmericanHigh RiskCirrhosisCalibrationRisk Prediction
Grant awards (9)
Statin Therapy for patients with compensated Cirrhosis$613,662
U01 · FY2025 · DK · contact PI
Statin Therapy for patients with compensated Cirrhosis$441,673
U01 · FY2024 · DK · contact PI
Statin Therapy for patients with compensated Cirrhosis$703,876
U01 · FY2023 · DK · contact PI
Statin Therapy for patients with compensated Cirrhosis$641,566
U01 · FY2022 · DK · contact PI
Optimizing Measures for Clinical Trials in Covert Hepatic Encephalopathy$194,400
K23 · FY2022 · DK · contact PI
Statin Therapy for patients with compensated Cirrhosis$366,344
U01 · FY2021 · DK · contact PI
Optimizing Measures for Clinical Trials in Covert Hepatic Encephalopathy$193,964
K23 · FY2021 · DK · contact PI
Optimizing Measures for Clinical Trials in Covert Hepatic Encephalopathy$193,720
K23 · FY2020 · DK · contact PI
Optimizing Measures for Clinical Trials in Covert Hepatic Encephalopathy$193,640
K23 · FY2019 · DK · contact PI